Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally
invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).
Phase:
Phase 3
Details
Lead Sponsor:
Daniel Hanley Johns Hopkins University
Collaborators:
Emissary International LLC Genentech, Inc. National Institute of Neurological Disorders and Stroke (NINDS)